drugset / Trial / NCT00460993

Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients

NCT00460993

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to examine the effects of the sleep aid Lunesta (Eszopiclone), on older adults who reside in a nursing home and have poor sleep as determined by wrist actigraphy.

Timeline

Start
2005-06
Primary completion
2008-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 2 mg

Indications

No indication recorded.